A study at The Cleveland Clinic has discovered that a gene – known as an androgen receptor (AR) is present in both breast and prostate cancers, but the gene has opposite effects on these diseases. The AR gene promotes prostate cancer when the gene is “turned on,” but in breast cancer the AR gene promotes [...]
According to research published today in the British Journal of Cancer, routine testing for a faulty BRCA2 gene (Kote-Jarai Z et al, BRCA2 is a gene contributing to young onset prostate cancer: implications for genetic testing in prostate cancer patients British Journal of Cancer (2011) doi:10.1038/bjc.2011.383) in men under 65 years with prostate cancer could [...]
From the Division of Cancer Prevention and Control Centers for Disease Control and Prevention Watch out for fever. If you get a fever during your chemotherapy treatment, it’s a medical emergency. […]
A retrospective study has just been published that shows that the risk of experiencing a biochemical recurrence (PSA recurrence) after radical prostatectomy to treat prostate cancer increased significantly in men who received alpha blockers for lower urinary tract symptoms (LUTS) after surgery. When compared to men who did not receive alpha blockers, those who did [...]
OK, I give up. I clearly don’t understand American politics! A new House proposal puts research funding at center of broader FY2012 budget debate, but not the way I would have predicted. In a surprise move the Republican House leaders released a draft proposal that would increase fiscal year 2012 funding for the National Institutes [...]